Abattis Bioceuticals
Vancouver
About Abattis Bioceuticals
Abattis Bioceuticals Corporation is a specialty bio-technology life sciences company that has acquired intellectual property, conducts research, and works to develop proprietary health and wellness solutions that address chronic illnesses and disease in animals and humans through proprietary and patent pending formulations. The Company has identified targeted channels to market and license proprietary patent pending products throughout the world. http://www.abattis.com/s/news.asp?ReportID=692690 SEDAR Filings: http://www.sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00011477
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $401.0K
- Funding stage: IPO
- Last round: Post-IPO Equity (Apr 2014)
- Ticker: cnsx:ATT
- Website: abattis.com
- Phone: (604) 538-6650
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/abattis-bioceuticals-2182635 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.